{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:15:21Z","timestamp":1775074521426,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2024GXNSFDA010035"],"award-info":[{"award-number":["2024GXNSFDA010035"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]},{"name":"Guangxi Medical High-level Key Talents Training \u201c139\u201d Program","award":["(2020)15"],"award-info":[{"award-number":["(2020)15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05142-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:06:47Z","timestamp":1751382407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dusp1 in osteolytic diseases-mechanisms and therapeutic potential"],"prefix":"10.1038","volume":"15","author":[{"given":"Boyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baicheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deshuang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohui","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5142_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jcp.2007.048868","volume":"61","author":"HK Datta","year":"2008","unstructured":"Datta, H. K., Ng, W. F., Walker, J. A., Tuck, S. P. & Varanasi, S. S. The cell biology of bone metabolism. J. Clin Pathol. 61, 577\u2013587 (2008).","journal-title":"J. Clin Pathol."},{"key":"5142_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fcell.2020.00507","volume":"8","author":"DS Gy\u0151ri","year":"2020","unstructured":"Gy\u0151ri, D. S. & M\u00f3csai, A. Osteoclast signal transduction during bone metastasis formation. Front. Cell Dev Biol. 8, 507 (2020).","journal-title":"Front. Cell Dev Biol."},{"key":"5142_CR3","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/stem.1450","volume":"31","author":"S Muruganandan","year":"2013","unstructured":"Muruganandan, S., Dranse, H. J., Rourke, J. L., McMullen, N. M. & Sinal, C. J. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells. 31, 2172\u20132182 (2013).","journal-title":"Stem Cells."},{"key":"5142_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","volume":"56","author":"N Takegahara","year":"2024","unstructured":"Takegahara, N., Kim, H. & Choi, Y. Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases. Exp. Mol Med. 56, 264\u2013272 (2024).","journal-title":"Exp. Mol Med."},{"key":"5142_CR5","doi-asserted-by":"publisher","first-page":"e82118","DOI":"10.7554\/eLife.82118","volume":"12","author":"K Inoue","year":"2023","unstructured":"Inoue, K. et al. Bone marrow Adipoq-lineage progenitors are a major cellular source of M-CSF that dominates bone marrow macrophage development, osteoclastogenesis, and bone mass. Elife 12, e82118 (2023).","journal-title":"Elife"},{"key":"5142_CR6","doi-asserted-by":"publisher","first-page":"e52481","DOI":"10.15252\/embr.202152481","volume":"22","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss. EMBO. Rep. 22, e52481 (2021).","journal-title":"EMBO. Rep."},{"key":"5142_CR7","doi-asserted-by":"publisher","first-page":"113140","DOI":"10.1016\/j.biopha.2022.113140","volume":"151","author":"T Liu","year":"2022","unstructured":"Liu, T. et al. Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways. Biomed. Pharmacother. 151, 113140 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"5142_CR8","doi-asserted-by":"publisher","first-page":"18797","DOI":"10.1038\/s41598-023-45909-3","volume":"13","author":"Y Omata","year":"2023","unstructured":"Omata, Y., Tachibana, H., Aizaki, Y., Mimura, T. & Sato, K. Essentiality of Nfatc1 short isoform in osteoclast differentiation and its self-regulation. Sci. Rep. 13, 18797 (2023).","journal-title":"Sci. Rep."},{"key":"5142_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson, C. L. et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch. Osteoporos. 17, 58 (2022).","journal-title":"Arch. Osteoporos."},{"key":"5142_CR10","doi-asserted-by":"publisher","first-page":"e0275020","DOI":"10.1371\/journal.pone.0275020","volume":"17","author":"YL Deng","year":"2022","unstructured":"Deng, Y. L. et al. Predictors for self-discontinuation of anti-osteoporosis medication: A hospital-based real-world study. PLoS ONE 17, e0275020 (2022).","journal-title":"PLoS ONE"},{"key":"5142_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/M22-0684","volume":"176","author":"C Ayers","year":"2023","unstructured":"Ayers, C. et al. Effectiveness and safety of treatments to Prevent fractures in people with low bone mass or primary osteoporosis: A living systematic review and network meta-analysis for the American College of Physicians. Ann. Intern Med. 176, 182\u2013195 (2023).","journal-title":"Ann. Intern Med."},{"key":"5142_CR12","doi-asserted-by":"publisher","first-page":"121255","DOI":"10.1016\/j.lfs.2022.121255","volume":"312","author":"M Pan","year":"2023","unstructured":"Pan, M. et al. Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy. Life. Sci. 312, 121255 (2023).","journal-title":"Life. Sci."},{"key":"5142_CR13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/art.42538","volume":"75","author":"J Zheng","year":"2023","unstructured":"Zheng, J. et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis. Rheumatol. 75, 1781\u20131792 (2023).","journal-title":"Arthritis. Rheumatol."},{"key":"5142_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12020-019-01919-8","volume":"64","author":"N Gua\u00f1abens","year":"2019","unstructured":"Gua\u00f1abens, N. et al. The next step after anti-osteoporotic drug discontinuation: An up-to-date review of sequential treatment. Endocrine 64, 441\u2013455 (2019).","journal-title":"Endocrine"},{"key":"5142_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","volume":"19","author":"I Foessl","year":"2023","unstructured":"Foessl, I., Dimai, H. P. & Obermayer-Pietsch, B. Long-term and sequential treatment for osteoporosis. Nat. Rev Endocrinol. 19, 520\u2013533 (2023).","journal-title":"Nat. Rev Endocrinol."},{"key":"5142_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.18632\/aging.100918","volume":"8","author":"FJ Cimas","year":"2016","unstructured":"Cimas, F. J., Callejas-Valera, J. C. & Sanchez-Prieto, R. MKP1: Jekyll and Hyde for E1A. Aging (Albany NY). 8, 214\u2013215 (2016).","journal-title":"Aging (Albany NY)."},{"key":"5142_CR17","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Mart\u00ednez, D. et al. Downregulation of snail by DUSP1 impairs cell migration and invasion through the inactivation of JNK and ERK and is useful as a predictive factor in the prognosis of prostate cancer. Cancers (Basel). 13, 1158 (2021).","DOI":"10.3390\/cancers13051158"},{"key":"5142_CR18","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.3390\/ijms19103004","volume":"19","author":"K Lee","year":"2018","unstructured":"Lee, K., Seo, I., Choi, M. H. & Jeong, D. Roles of mitogen-activated protein kinases in osteoclast biology. Int J. Mol Sci. 19, 3004 (2018).","journal-title":"Int J. Mol Sci."},{"key":"5142_CR19","doi-asserted-by":"crossref","unstructured":"Ambrosi, T. H. et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature. 597, 256\u2013262 (2021).","DOI":"10.1038\/s41586-021-03795-7"},{"key":"5142_CR20","doi-asserted-by":"publisher","first-page":"R98","DOI":"10.1186\/ar2485","volume":"10","author":"R Huber","year":"2008","unstructured":"Huber, R. et al. Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis. Res Ther. 10, R98 (2008).","journal-title":"Arthritis. Res Ther."},{"key":"5142_CR21","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1177\/0022034509349306","volume":"88","author":"R Sartori","year":"2009","unstructured":"Sartori, R., Li, F. & Kirkwood, K. L. MAP kinase phosphatase-1 protects against inflammatory bone loss. J. Dent Res. 88, 1125\u20131130 (2009).","journal-title":"J. Dent Res."},{"key":"5142_CR22","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","volume":"10","author":"JM Kim","year":"2020","unstructured":"Kim, J. M., Lin, C., Stavre, Z., Greenblatt, M. B. & Shim, J. H. Osteoblast-osteoclast communication and bone homeostasis. Cells 10, 2073 (2020).","journal-title":"Cells"},{"key":"5142_CR23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid, I. R. & Billington, E. O. Drug therapy for osteoporosis in older adults. Lancet 399, 1080\u20131092 (2022).","journal-title":"Lancet"},{"key":"5142_CR24","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1152\/ajpendo.00577.2013","volume":"308","author":"A Khadir","year":"2015","unstructured":"Khadir, A. et al. MAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exercise. Am J. Physiol Endocrinol Metab. 308, E71-83 (2015).","journal-title":"Am J. Physiol Endocrinol Metab."},{"key":"5142_CR25","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1038\/s41467-023-40788-8","volume":"14","author":"D Strebinger","year":"2023","unstructured":"Strebinger, D. et al. Cell type-specific delivery by modular envelope design. Nat. Commun. 14, 5141 (2023).","journal-title":"Nat. Commun."},{"key":"5142_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymthe.2006.05.015","volume":"14","author":"DS An","year":"2006","unstructured":"An, D. S. et al. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol. Ther. 14, 494\u2013504 (2006).","journal-title":"Mol. Ther."},{"key":"5142_CR27","doi-asserted-by":"publisher","first-page":"e75610","DOI":"10.7554\/eLife.75610","volume":"11","author":"M Portes","year":"2022","unstructured":"Portes, M. et al. Nanoscale architecture and coordination of actin cores within the sealing zone of human osteoclasts. Elife 11, e75610 (2022).","journal-title":"Elife"},{"key":"5142_CR28","doi-asserted-by":"crossref","unstructured":"Shen, S. et al. Leucine repeat rich kinase 1 controls osteoclast activity by managing lysosomal trafficking and secretion. Biology (Basel). 12, 511 (2023).","DOI":"10.3390\/biology12040511"},{"key":"5142_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10020-022-00449-w","volume":"28","author":"D Ke","year":"2022","unstructured":"Ke, D., Yu, Y., Li, C., Han, J. & Xu, J. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis. Mol. Med. 28, 22 (2022).","journal-title":"Mol. Med."},{"key":"5142_CR30","doi-asserted-by":"publisher","first-page":"7727006","DOI":"10.1155\/2022\/7727006","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. MCU inhibitor ruthenium red alleviates the osteoclastogenesis and ovariectomized osteoporosis via suppressing RANKL-induced ROS production and NFATc1 activation through P38 MAPK signaling pathway. Oxid. Med Cell Longev. 2022, 7727006 (2022).","journal-title":"Oxid. Med Cell Longev."},{"key":"5142_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri, M. et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp Med. 202, 1261\u20131269 (2005).","journal-title":"J. Exp Med."},{"key":"5142_CR32","doi-asserted-by":"publisher","first-page":"645140","DOI":"10.3389\/fphar.2021.645140","volume":"12","author":"J He","year":"2021","unstructured":"He, J. et al. Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity. Front. Pharmacol. 12, 645140 (2021).","journal-title":"Front. Pharmacol."},{"key":"5142_CR33","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1359\/jbmr.081239","volume":"24","author":"H Wu","year":"2009","unstructured":"Wu, H., Xu, G. & Li, Y. P. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J. Bone Miner Res. 24, 871\u2013885 (2009).","journal-title":"J. Bone Miner Res."},{"key":"5142_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2302\/kjm.60.101","volume":"60","author":"T Miyamoto","year":"2011","unstructured":"Miyamoto, T. Regulators of osteoclast differentiation and cell\u2013cell fusion. Keio. J. Med. 60, 101\u2013105 (2011).","journal-title":"Keio. J. Med."},{"key":"5142_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/72855","volume":"24","author":"K Matsuo","year":"2000","unstructured":"Matsuo, K. et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24, 184\u2013187 (2000).","journal-title":"Nat. Genet."},{"key":"5142_CR36","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1002\/jcb.28504","volume":"120","author":"M Pang","year":"2019","unstructured":"Pang, M. et al. AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors. J. Cell Biochem. 120, 12382\u201312392 (2019).","journal-title":"J. Cell Biochem."},{"key":"5142_CR37","doi-asserted-by":"crossref","unstructured":"Ga\u0142ga\u0144ska, H., Jarmuszkiewicz, W., Ga\u0142ga\u0144ski, \u0141. Carbon dioxide and MAPK signalling: towards therapy for inflammation. Cell Commun Signal. 21, 280 (2023).","DOI":"10.1186\/s12964-023-01306-x"},{"key":"5142_CR38","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.3390\/ijms25095047","volume":"25","author":"AT Loukas","year":"2024","unstructured":"Loukas, A. T. et al. Natural compounds for bone remodeling: a computational and experimental approach targeting bone metabolism-related proteins. Int J. Mol Sci. 25, 5047 (2024).","journal-title":"Int J. Mol Sci."},{"key":"5142_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1196\/annals.1346.014","volume":"1068","author":"FP Ross","year":"2006","unstructured":"Ross, F. P. M-CSF, c-Fms, and signaling in osteoclasts and their precursors. Ann. N Y. Acad Sci. 1068, 110\u2013116 (2006).","journal-title":"Ann. N Y. Acad Sci."},{"key":"5142_CR40","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1359\/jbmr.080211","volume":"23","author":"F Ikeda","year":"2008","unstructured":"Ikeda, F. et al. JNK\/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. J. Bone Miner Res. 23, 907\u2013914 (2008).","journal-title":"J. Bone Miner Res."},{"key":"5142_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jcp.21283","volume":"215","author":"A Mozar","year":"2008","unstructured":"Mozar, A. et al. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells. J. Cell Physiol. 215, 47\u201354 (2008).","journal-title":"J. Cell Physiol."},{"key":"5142_CR42","doi-asserted-by":"crossref","unstructured":"Wagner, E. F., Matsuo, K. Signalling in osteoclasts and the role of Fos\/AP1 proteins. Ann. Rheum Dis. 62 Suppl 2, ii83\u201385 (2003).","DOI":"10.1136\/ard.62.suppl_2.ii83"},{"key":"5142_CR43","doi-asserted-by":"crossref","unstructured":"Matsumoto, M. et al. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 279, 45969\u201345979 (2004).","DOI":"10.1074\/jbc.M408795200"},{"key":"5142_CR44","doi-asserted-by":"crossref","unstructured":"Ghosh, S. S., Wang, J., Yannie, P. J. Ghosh, S. Intestinal barrier dysfunction, LPS translocation, and disease development. J. Endocr. Soc. 4, bvz039 (2020).","DOI":"10.1210\/jendso\/bvz039"},{"key":"5142_CR45","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/cells9030728","volume":"9","author":"S Park","year":"2020","unstructured":"Park, S. et al. SIRT1 alleviates LPS-induced IL-1\u03b2 production by suppressing NLRP3 inflammasome activation and ROS production in trophoblasts. Cells 9, 728 (2020).","journal-title":"Cells"},{"key":"5142_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-024-00722-y","volume":"19","author":"GC Brown","year":"2024","unstructured":"Brown, G. C. & Heneka, M. T. The endotoxin hypothesis of Alzheimer\u2019s disease. Mol. Neurodegener. 19, 30 (2024).","journal-title":"Mol. Neurodegener."},{"key":"5142_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11914-024-00867-1","volume":"22","author":"IAG Brandt","year":"2024","unstructured":"Brandt, I. A. G., Starup-Linde, J., Andersen, S. S. & Viggers, R. Diagnosing osteoporosis in diabetes-A systematic review on BMD and fractures. Curr. Osteoporos Rep. 22, 223\u2013244 (2024).","journal-title":"Curr. Osteoporos Rep."},{"key":"5142_CR48","doi-asserted-by":"publisher","first-page":"1151837","DOI":"10.3389\/fpubh.2023.1151837","volume":"11","author":"Z Dai","year":"2023","unstructured":"Dai, Z. et al. Two-sample Mendelian randomization analysis evaluates causal associations between inflammatory bowel disease and osteoporosis. Front. Public Health. 11, 1151837 (2023).","journal-title":"Front. Public Health."},{"key":"5142_CR49","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bbrc.2010.10.103","volume":"402","author":"K Bandow","year":"2010","unstructured":"Bandow, K. et al. Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation. Biochem. Biophys Res Commun. 402, 755\u2013761 (2010).","journal-title":"Biochem. Biophys Res Commun."},{"key":"5142_CR50","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.4049\/jimmunol.166.5.3574","volume":"166","author":"T Kikuchi","year":"2001","unstructured":"Kikuchi, T. et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 166, 3574\u20133579 (2001).","journal-title":"J. Immunol."},{"key":"5142_CR51","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1359\/jbmr.2001.16.11.2082","volume":"16","author":"Y Bi","year":"2001","unstructured":"Bi, Y. et al. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J. Bone Miner Res. 16, 2082\u20132091 (2001).","journal-title":"J. Bone Miner Res."},{"key":"5142_CR52","doi-asserted-by":"crossref","unstructured":"Bott, KN. et al. Lipopolysaccharide-induced bone loss in rodent models: a systematic review and meta-analysis. J. Bone Miner Res. 38, 198\u2013213 (2023).","DOI":"10.1002\/jbmr.4740"},{"key":"5142_CR53","doi-asserted-by":"publisher","first-page":"C81","DOI":"10.1152\/ajpcell.2000.278.1.C81","volume":"278","author":"N Begum","year":"2000","unstructured":"Begum, N. & Ragolia, L. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. Am J. Physiol Cell Physiol. 278, C81-91 (2000).","journal-title":"Am J. Physiol Cell Physiol."},{"key":"5142_CR54","doi-asserted-by":"crossref","unstructured":"Taira TM. et al. HBP\/O-GlcNAcylation metabolic axis regulates bone resorption outcome. J. Dent Res. 102, 440\u2013449 (2023).","DOI":"10.1177\/00220345221141043"},{"key":"5142_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12974-019-1658-2","volume":"16","author":"H Zeng","year":"2019","unstructured":"Zeng, H. et al. Lentivirus-mediated downregulation of \u03b1-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury. J. Neuroinflammation. 16, 283 (2019).","journal-title":"J. Neuroinflammation."},{"key":"5142_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0271678X211039997","volume":"42","author":"L Skukan","year":"2022","unstructured":"Skukan, L. et al. Lentivirus- or AAV-mediated gene therapy interventions in ischemic stroke: A systematic review of preclinical in vivo studies. J. Cereb Blood Flow Metab. 42, 219\u2013236 (2022).","journal-title":"J. Cereb Blood Flow Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05142-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:06:49Z","timestamp":1751382409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05142-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5142"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05142-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Animal Ethics Committee of Guangxi Medical University approved the study (No. 202212012).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study does not involve human subjects or human tissue.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patients consent for publication"}}],"article-number":"20887"}}